Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04431258
Title ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study (PanC-ASAP)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ability Pharmaceuticals SL

pancreatic ductal adenocarcinoma

pancreatic adenocarcinoma

pancreatic carcinoma


ABTL0812 + Fluorouracil + Irinotecan + Oxaliplatin

Fluorouracil + Irinotecan + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA | ESP

No variant requirements are available.